| Serial Number | 79349582 |
| Word Mark | EDIGENE |
| Filing Date | Monday, April 18, 2022 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, November 21, 2023 |
| Registration Number | 7220629 |
| Registration Date | Tuesday, November 21, 2023 |
| Mark Drawing | 5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
| Published for Opposition Date | Tuesday, September 5, 2023 |
| Description of Mark | The mark consists of the stylized wording "EDIGENE". |
| Goods and Services | Biological preparations for medical purposes for the treatment of gene mutation related diseases, hematological diseases and psychiatric and immune system related diseases and disorders; styptic preparations; medicines for human purposes, namely, medicines for the treatment of diabetes, obesity, cancer, viral, metabolic, endocrine, musculoskeletal, oncological diseases, cardiovascular and cerebrovascular diseases, respiratory diseases and asthma, gastrointestinal diseases, genitourinary diseases, neurological diseases, allergies, headaches, insomnia, bacteria-based diseases, ocular disorders or diseases; pharmaceutical preparations, namely, antivirals, pharmaceutical preparations for suppressing tumors, pharmaceutical preparations for the treatment of cancers; stem cells for medical purposes; surgical implants comprised of living tissues; blood for medical purposes; biological preparations for the treatment of cancer; pharmaceutical preparations for activating cellular function; cytostatics for medical purposes; living cells for medical use; ophthalmological preparations; pharmaceutical products for ophthalmological use; cord blood for medical purposes |
| Goods and Services | Biotechnology research; scientific research for medical purposes in the area of cancerous diseases; genetic testing for scientific research purposes; structural and functional analysis of genomes; DNA screening for scientific research purposes; conducting early evaluations in the field of new pharmaceuticals; pharmaceutical research services; analysis of the mode of action of chemical combinations on animals; technological research in the field of novel drug development; scientific laboratory services; chemical research; biological research; scientific research in the nature of conducting clinical trials for others; medical research |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, September 16, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, September 16, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | EDIGENE INC. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | CN |
| Party Name | EDIGENE INC. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | CN |
| Party Name | EDIGENE INC. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | CN |
| Event Date | Event Description |
| Monday, March 18, 2024 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Monday, February 26, 2024 | FINAL DISPOSITION NOTICE SENT TO IB |
| Monday, February 26, 2024 | FINAL DISPOSITION PROCESSED |
| Wednesday, February 21, 2024 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Tuesday, November 21, 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Tuesday, November 21, 2023 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, September 5, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, September 5, 2023 | PUBLISHED FOR OPPOSITION |
| Monday, September 4, 2023 | NOTIFICATION PROCESSED BY IB |
| Wednesday, August 16, 2023 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, August 16, 2023 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Wednesday, August 16, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Monday, July 31, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, July 19, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, July 18, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, July 18, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, April 20, 2023 | REFUSAL PROCESSED BY IB |
| Wednesday, March 29, 2023 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Wednesday, March 29, 2023 | REFUSAL PROCESSED BY MPU |
| Saturday, February 4, 2023 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Friday, February 3, 2023 | NON-FINAL ACTION WRITTEN |
| Thursday, February 2, 2023 | ASSIGNED TO EXAMINER |
| Tuesday, September 20, 2022 | APPLICATION FILING RECEIPT MAILED |
| Friday, September 16, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, September 15, 2022 | SN ASSIGNED FOR SECT 66A APPL FROM IB |